Endotracheal tube is used to provide artificial airway. These tubes are commonly known as ET or ETT tube. Endotracheal means through the trachea. Endotracheal intubation involves insertion of ET tubes into windpipe through the mouth or nose. Nasal route is less frequently used compared to oral route for intubation. Endotracheal intubation is a medical procedure performed to mechanically ventilate a patient suffering from brain injury to keep airway open. The cuff is an important part present outside the endotracheal tube. Various sizes of ET tubes are available in the market based on personal anatomy and surgery type.
The two primary causes of ventilator-associated pneumonia (VAP) are microaspiration and biofilm formation. Non-coated endotracheal tubes are more prone to cause ventilator-associated pneumonia. Coated endotracheal tube is a new and emerging trend in the global endotracheal tubes market, as it reduces bacterial adhesion and biofilm formation on endotracheal tube surface. Coated endotracheal tube has a coating of a drug and materials such as heparin, silver, chlohexidine, and rifamicin with broad spectrum of antimicrobial activity. Clinical studies have shown reduction in cases of ventilator-associated pneumonia when uncoated endotracheal tube was replaced by coated endotracheal tube. Hence, increase in incidence of ventilator-associated pneumonia, awareness about technologically advanced endotracheal tube, and developments in the field of nanobiotechnology and drug design are the key factors projected to drive the global coated endotracheal tubes market.
Risks associated with manufacturing defects or intubation such as bleeding and higher cost of coated endotracheal tube than non-coated endotracheal tube are anticipated to negatively impact the global coated endotracheal tubes market. Innovations in ETT design are focusing on various parameters such as ETT cuff material, shape, cuff pressure, and volume, and addition of nano-pressure devices for effective sealing. These factors are expected to propel the global coated endotracheal tubes market in the near future.
The global coated endotracheal tubes market can be segmented based on application, intubation, end-user, and region. In terms of intubation, the market can be bifurcated into oral and nasal. Mouth is the most preferred route for intubation of endotracheal tube, as oral endotracheal intubation is easier to perform and less painful. Hence, oral is likely to be the fastest growing segment during the forecast period. However, advancement in the field of polymer science and increase in knowledge about antimicrobial activity of metals are projected to propel the nasal segment from 2018 to 2026.
Based on application, the global coated endotracheal tubes market can be classified into anesthesia, lung or mouth cancer, congenital respiratory disorder, brain injury, and others. Anesthesia is anticipated to be the fastest growing segment during the forecast period as to supplement patient with anesthetic gases or drugs endotracheal tubes are mostly preferred hence propelling the growth of the segment.
In terms of end user, the global coated endotracheal tubes market can be divided into clinics, hospital, ambulatory surgical center, and others. Hospitals purchase endotracheal tubes from key players in bulk. Hence, hospitals is one of the major segments of the global coated endotracheal tubes market. Emergence and shift toward specialized healthcare center are expected to augment the ambulatory surgical centers segment during the forecast period.
In terms of region, the global coated endotracheal tubes market can be segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America and Europe are the leading markets for coated endotracheal tubes due to presence of several high-income countries with strong health care infrastructure. Asia Pacific is expected to lead the global coated endotracheal tubes market during the forecast period, as large number of cases of cardiac and respiratory arrest are reported every year.
Key players operating in the global coated endotracheal tubes market are C. R. Bard, Inc., BACTIGUARD, Enox Biopharma, Inc., Innovative Surface Technologies, Inc., N8 Medical, LLC, Sharklet Technologies, Sonoma Pharmaceuticals, and Teleflex Incorporated.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.